Patents Assigned to Bacchus Vascular, Inc.
-
Publication number: 20110046542Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.Type: ApplicationFiled: June 15, 2010Publication date: February 24, 2011Applicant: Bacchus Vascular Inc.Inventors: Michael A. Evans, Denise Demarias, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
-
Patent number: 7763010Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.Type: GrantFiled: May 8, 2002Date of Patent: July 27, 2010Assignee: Bacchus Vascular inc.Inventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
-
Publication number: 20090177259Abstract: The present invention provides for treatment of ostial occlusions through placement of scaffold in a side-branch adjacent the ostium.Type: ApplicationFiled: January 3, 2008Publication date: July 9, 2009Applicant: Bacchus Vascular, Inc.Inventors: Kelvin Ning, Richard Scott Rader
-
Patent number: 7517352Abstract: The present invention provides devices, systems, methods and kits for the percutaneous removal of unwanted tissue or obstructive matter from body cavities or lumens, particularly from the vasculature. Blood vessels, including the coronary, peripheral and neurovascular circulation, which are narrowed or blocked by atheromatous material or plaque are often treated with traditional endarterectomy procedures. The present invention allows the benefits of such a procedure with an intraluminal approach, particularly a percutaneous approach. Generally, the present invention provides a set of catheters or tools which are percutaneously introduceable to the site of the blockage or occlusion. The tools dissect or cut through the innermost tissue layer of the lumen to an underlying tissue layer. The innermost tissue layer is then stripped away from the underlying layer with the occlusive material thereattached.Type: GrantFiled: March 27, 2001Date of Patent: April 14, 2009Assignee: Bacchus Vascular, Inc.Inventors: Michael Evans, Denise Demarais, Gwendolyn Watanabe, Stephen Leeflang
-
Patent number: 7399307Abstract: An apparatus for treating an occlusive region of a blood vessel includes a catheter including a first lumen extending from an end port to a first side port, and a second lumen extending from a proximal end of the catheter to a second side port. A balloon is mounted on the catheter between the first and second side ports. During use, a guidewire is placed into an occlusive region, and the guidewire is backloaded through the first and second lumens. The catheter is advanced over the guidewire, and the balloon is expanded to isolate the occlusive region. The guidewire is removed, and an agitator is advanced through the second lumen. After the agitator is agitated to dislodge occlusive material from the occlusive region, the agitator is removed, and the loose occlusive material is aspirated via the second side port.Type: GrantFiled: May 13, 2003Date of Patent: July 15, 2008Assignee: Bacchus Vascular, Inc.Inventors: Michael A. Evans, Denise Demarais, Alexander Khairkhahan, Dino Decicco
-
Patent number: 6945977Abstract: Thrombectomy and other treatments are achieved using a catheter having a positioning cage and a macerator within the positioning cage. The catheter is introduced to a target body lumen, typically a blood vessel, and a positioning cage deployed at a treatment site. The macerator is then operated to disrupt thrombus, clot, or other occlusive materials at the treatment site, and the catheter is used to collect and remove the disruptive materials from the body lumen. In particular examples, the macerator may be radially expansible and optionally rotated and/or axially translated within the positioning cage to effect disruption of the occlusive material.Type: GrantFiled: October 6, 2003Date of Patent: September 20, 2005Assignee: Bacchus Vascular, Inc.Inventors: Denise Demarais, Michael A. Evans, Stephen A. Leeflang, Christian S. Eversull
-
Patent number: 6936025Abstract: A catheter suitable for dissolving blockages in tubular tissue provides a combination of low frequency (1–100 Hz) vibratory motion and injection of a lysing agent. The tubular tissue may be veins, arteries, ducts, intestines, or any other blocked body lumen. For vascular thrombi, the catheter may induce a vibrating, stirring action in and around the thrombus in combination with dispensing of a thrombolytic agent, such as urokinase, into the thrombus. An inflatable or expandable member may be provided near a distal tip of the catheter to prevent release of dislodged thrombus.Type: GrantFiled: November 1, 2000Date of Patent: August 30, 2005Assignee: Bacchus Vascular, Inc.Inventors: Michael Evans, Will R. Dubrul
-
Patent number: 6929633Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, agitate the clot and agent, and aspirate broken-up clot from the blood vessel. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.Type: GrantFiled: October 21, 2002Date of Patent: August 16, 2005Assignee: Bacchus Vascular, Inc.Inventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang, Jody Maria Cimbalo, Stephen Leeflang
-
Publication number: 20040219028Abstract: Material transport catheters and methods for their use rely on rotation of an impeller within a catheter body and a clearing element for preventing buildup of materials at the opening of the catheter body. The impeller preferably comprises an inner tube or shaft having a helical rotor formed over an outer surface thereof. The clearing element may comprise a free end of a structure near the distal end of the catheter body for disrupting clot, wherein the free end of the structure extends into the distal opening of the catheter body to break up materials as the impeller is rotated. Alternatively, the clearing element may comprise a cutting member disposed at the distal opening of the catheter body.Type: ApplicationFiled: March 9, 2004Publication date: November 4, 2004Applicant: BACCHUS VASCULAR INC., A Delaware CorporationInventors: Denise M. Demarais, Stephen A. Leeflang, Michael A. Evans, Gwendolyn A. Watanabe, John C. Tanner, Christian S. Eversull
-
Publication number: 20040181150Abstract: Access to blood vessels and other body lumens is provided from spaced-apart access penetrations. A penetrating device is introduced through a first access penetration to a target site within the body lumen and then used to penetrate outwardly from the body lumen to an external surface on an organ or the patient's skin. A guidewire may then be deployed through the penetrating device, and the penetrating device removed to leave the guidewire in place. Catheters and other interventional and diagnostic devices may then be introduced to the target site from either or both of the first and second access penetrations over the same guidewire.Type: ApplicationFiled: March 29, 2004Publication date: September 16, 2004Applicant: BACCHUS VASCULAR, INC.Inventors: Michael A. Evans, Denise M. Demarais
-
Publication number: 20040098033Abstract: An apparatus includes a jet housing including an inlet and an outlet, and a nozzle within the jet housing for injecting fluid towards the outlet. A filter element is disposed on the inlet, the filter element including openings for preventing particulate larger than a predetermined size from entering the inlet. The jet housing is positioned within a blood vessel, and fluid is injected from the nozzle towards the outlet to create a vacuum at the inlet, thereby causing fluid downstream of the outlet to flow retrograde through the vessel around the jet housing into the inlet. The filter element prevents particulate from entering the inlet, thereby effectively capturing the particulate, which may be aspirated. Alternatively, a filter element is used to filter particulate during a procedure. The filter element everts from a tubular to an everted configuration for capturing particulate.Type: ApplicationFiled: October 1, 2003Publication date: May 20, 2004Applicant: BACCHUS VASCULAR, INC.Inventors: Stephen A. Leeflang, Denise DeMarais, Michael A. Evans
-
Publication number: 20040082962Abstract: Thrombectomy and other treatments are achieved using a catheter having a positioning cage and a macerator within the positioning cage. The catheter is introduced to a target body lumen, typically a blood vessel, and a positioning cage deployed at a treatment site. The macerator is then operated to disrupt thrombus, clot, or other occlusive materials at the treatment site, and the catheter is used to collect and remove the disruptive materials from the body lumen. In particular examples, the macerator may be radially expansible and optionally rotated and/or axially translated within the positioning cage to effect disruption of the occlusive material.Type: ApplicationFiled: October 6, 2003Publication date: April 29, 2004Applicant: BACCHUS VASCULAR, INC.Inventors: Denise Demarais, Michael A. Evans, Stephen A. Leeflang, Christian S. Eversull
-
Patent number: 6702830Abstract: Material transport catheters and methods for their use rely on rotation of an impeller within a catheter body. The impeller preferably comprises an inner tube or shaft having a helical rotor formed over an outer surface thereof. Optionally, in the case of a tubular shaft, a second helical rotor may be provided within the shaft lumen in order to induce flow in opposite or in the same direction as induced by the outer helical rotor. Catheters may further comprise structures near their distal ends for disrupting clot, and are preferably introduceable over guidewires where the helical rotors are rotated directly over the guidewire. The catheters may include two or more impellers or impellers having two or more rotors in order to provide for circulation of materials at a target site within a patient body lumen.Type: GrantFiled: June 9, 2000Date of Patent: March 9, 2004Assignee: Bacchus Vascular, Inc.Inventors: Denise M. Demarais, Stephen A. Leeflang, Michael A. Evans, Gwendolyn A. Watanabe, John C. Tanner, III, Christian S. Eversull
-
Publication number: 20040006306Abstract: An apparatus for treating an occlusive region of a blood vessel includes a catheter including a first lumen extending from an end port to a first side port, and a second lumen extending from a proximal end of the catheter to a second side port. A balloon is mounted on the catheter between the first and second side ports. During use, a guidewire is placed into an occlusive region, and the guidewire is backloaded through the first and second lumens. The catheter is advanced over the guidewire, and the balloon is expanded to isolate the occlusive region. The guidewire is removed, and an agitator is advanced through the second lumen. After the agitator is agitated to dislodge occlusive material from the occlusive region, the agitator is removed, and the loose occlusive material is aspirated via the second side port.Type: ApplicationFiled: May 13, 2003Publication date: January 8, 2004Applicant: BACCHUS VASCULAR INC.Inventors: Michael A. Evans, Denise Demarais, Alexander Khairkhahan, Dino Decicco
-
Patent number: 6663613Abstract: Clot disruption and dissolution are achieved using a catheter having both an agitator and the ability to deliver a thrombolytic agent. The catheter is introduced to a target region with a blood vessel and the agitator manipulated to engage and disrupt a region of clot therein. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.Type: GrantFiled: January 25, 2000Date of Patent: December 16, 2003Assignee: Bacchus Vascular, Inc.Inventors: Michael A. Evans, Denise M. Demarais, Christian S. Eversull, Stephen A. Leeflang
-
Patent number: 6660014Abstract: Thrombectomy and other treatments are achieved using a catheter having a positioning cage and a macerator within the positioning cage. The catheter is introduced to a target body lumen, typically a blood vessel, and a positioning cage deployed at a treatment site. The macerator is then operated to disrupt thrombus, clot, or other occlusive materials at the treatment site, and the catheter is used to collect and remove the disruptive materials from the body lumen. In particular examples, the macerator may be radially expansible and optionally rotated and/or axially translated within the positioning cage to effect disruption of the occlusive material.Type: GrantFiled: June 3, 2002Date of Patent: December 9, 2003Assignee: Bacchus Vascular, Inc.Inventors: Denise Demarais, Michael A. Evans, Stephen A. Leeflang, Christian S. Eversull
-
Patent number: 6652548Abstract: Devices, methods, kits, and methods remove clot material from the vasculature and other body lumens. Expansible baskets may be used as cooperating radially expansible shearing members. Helically oriented struts of each basket may wind in a uniform circumferential direction. The struts can be independently flexible, allowing the shearing members to flex axially together. The inner basket may be rotatably driven and may use an axial pump extending proximally from the shearing members and/or a distal penetrator for advancing into an occlusion which inhibits guidewire access. The struts may slide substantially continuously across each other, and may be sufficiently aggressive for highly effective thrombectomy.Type: GrantFiled: March 30, 2001Date of Patent: November 25, 2003Assignee: Bacchus Vascular Inc.Inventors: Michael A. Evans, Denise M. Demarais, Stephen A. Leeflang, Christian S. Eversull
-
Patent number: 6635070Abstract: An apparatus includes a jet housing including an inlet and an outlet, and a nozzle within the jet housing for injecting fluid towards the outlet. A filter element is disposed on the inlet, the filter element including openings for preventing particulate larger than a predetermined size from entering the inlet. The jet housing is positioned within a blood vessel, and fluid is injected from the nozzle towards the outlet to create a vacuum at the inlet, thereby causing fluid downstream of the outlet to flow retrograde through the vessel around the jet housing into the inlet. The filter element prevents particulate from entering the inlet, thereby effectively capturing the particulate, which may be aspirated. Alternatively, a filter element is used to filter particulate during a procedure. The filter element everts from a tubular to an everted configuration for capturing particulate.Type: GrantFiled: May 21, 2001Date of Patent: October 21, 2003Assignee: Bacchus Vascular, Inc.Inventors: Stephen Leeflang, Denise DeMarais, Michael Evans
-
Publication number: 20030139751Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, agitate the clot and agent, and aspirate broken-up clot from the blood vessel. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.Type: ApplicationFiled: October 21, 2002Publication date: July 24, 2003Applicant: BACCHUS VASCULAR INC.Inventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang, Jody Maria Cimbalo, Stephen Leeflang
-
Publication number: 20030083608Abstract: The present invention describes a catheter suitable for introduction into a tubular tissue for dissolving blockages in such tissue. The catheter is particularly useful for removing thrombi within blood vessels. In accordance with the preferred embodiments, a combination of vibrating motion and injection of a lysing agent is utilized to break up blockages in vessels. The vessels may be veins, arteries, ducts, intestines, or any lumen within the body that may become blocked from the material that flows through it. As a particular example, dissolution of vascular thrombi facilitated by advancing a catheter through the occluded vessel, the catheter causing a vibrating, stirring action in and around the thrombus usually in combination with the dispensing of a thrombolytic agent such as urokinase into the thrombus. The catheter has an inflatable or expandable member near the distal tip which, when inflated or expanded, prevents the passage of dislodged thrombus around the catheter.Type: ApplicationFiled: July 1, 2002Publication date: May 1, 2003Applicant: Bacchus Vascular, Inc.Inventors: Michael Evans, Will R. DuBrul